-
Photocure initiates enrollment into phase II trial of Cevira® for cervical HPV infectionFirst study to evaluate optimal dose of novel integrated drug-delivery device First novel therapeutic treatment option for highly prevalent cervical HPV infections and precancerous lesions22 Jun 2011 -
Hexvix®/Cysview™ demonstrates long term benefit12 May 2011
-
British Journal of Urology publishes paper on Hexvix®Demonstrates significant reduction in recurrence of bladder cancer23 Mar 2011
-
Photocure announces positive preliminary results from the Allumera™ consumer trialAllumera™ shows significant improvements in appearance of skin compared to light29 Nov 2010
